Clinical Trial Update: A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating povetacicept in adults with generalized myasthenia gravis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Povetacicept (povetacicept)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Myasthenia Gravis, Generalized | Phase 2 | Status: RECRUITING